Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York

Tamar A Smith-Norowitz; Jonathan I Silverberg; Esther M Norowitz; Stephan Kohlhoff; Margaret R Hammerschlag

doi:10.1080/21645515.2021.1948786

Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York

Hum Vaccin Immunother. 2021 Nov 2;17(11):4013-4014. doi: 10.1080/21645515.2021.1948786. Epub 2021 Jul 9.

Authors

Tamar A Smith-Norowitz¹, Jonathan I Silverberg², Esther M Norowitz¹, Stephan Kohlhoff¹, Margaret R Hammerschlag¹

Affiliations

¹ Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Medical Center, Brooklyn, NY, USA.
² Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Abstract

The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspotAbbreviations: COVID-19: coronavirus disease-19.

Keywords: COVID-19; COVID-19 vaccine; New York; seasonal influenza vaccine; vaccine hesitancy.

MeSH terms

Adolescent
Adult
COVID-19 Vaccines
COVID-19*
Cross-Sectional Studies
Humans
New York
SARS-CoV-2
Vaccination
Vaccination Hesitancy
Vaccine Efficacy

Substances

COVID-19 Vaccines

Grants and funding

The authors have no funding to disclose.